Storia della carriera di Jerome Bailey
Precedenti posizioni note di Jerome Bailey
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LONGEVERON INC. | Direttore operativo | 15/09/2022 | 01/04/2024 |
| CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Formazione di Jerome Bailey
| Rutgers State University of New Jersey | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Francia | 2 |
Posizioni
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Jerome Bailey
- Esperienza
